EMN
52
-4
AMZN
56
5
RL
66
-2
PSX
30
-2
RIG
55
-3
MA
58
3
BA
53
5
FFIV
67
-2
XOM
40
-2
ETR
66
-9
NTRS
49
-3
CMI
47
-2
MAC
62
-3
DUK
37
-3
IRM
63
-2
DG
23
2
MLM
60
-7
CFG
54
-4
PM
60
-8
ROK
52
2
EMN
52
-4
AMZN
56
5
RL
66
-2
PSX
30
-2
RIG
55
-3
MA
58
3
BA
53
5
FFIV
67
-2
XOM
40
-2
ETR
66
-9
NTRS
49
-3
CMI
47
-2
MAC
62
-3
DUK
37
-3
IRM
63
-2
DG
23
2
MLM
60
-7
CFG
54
-4
PM
60
-8
ROK
52
2
Financhill
Back

Compugen Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
24

CGEN
Compugen

Last Price:
1.65
Seasonality Move:
24.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Compugen Price Quote

$1.65
+0.01 (+-3.51%)
(Updated: November 5, 2024 at 3:05 AM ET)

Compugen Key Stats

Sell
24
Compugen (CGEN) is a Sell
Day range:
$1.63 - $1.68
52-week range:
$0.53 - $3.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.52%
Volume:
152.5K
Avg. volume:
192.6K
1-year change:
120.96%
Market cap:
$146.8M
Revenue:
$33.5M
EPS:
$-0.09

How Much Does Compugen Make?

Data Unavailable

Is Compugen Growing As A Company?

Data Unavailable

Compugen Stock Price Performance

  • Did Compugen Stock Go Up Last Month?
    Compugen share price went down by -10.38% last month
  • Did CGEN's Share Price Rise Over The Last Year?
    CGEN share price rose by 120.96% over the past 1 year

What Is Compugen 52-Week High & Low?

  • What Is Compugen’s 52-Week High Share Price?
    Compugen has traded as high as $3.03 over the past 52 weeks
  • What Is Compugen’s 52-Week Low Share Price?
    Compugen has traded as low as $0.53 over the past 52 weeks

Compugen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Compugen?

  • How Much Debt Does Compugen Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Compugen Have?
    Cash and short term investments quarterly total is $92M
  • What Is Compugen’s Book Value Per Share?
    Book value per share is 0.65

Is Compugen Cash Flow Positive?

Data Unavailable

Compugen Return On Invested Capital

  • Is Management Doing A Good Job?
    CGEN return on invested capital is -15.95%
  • What Is Compugen Return On Assets?
    ROA measures how assets are converting to revenues and is -9.73%
  • What Is CGEN Return On Equity?
    ROE is a measure of profitability and is -15.95%

Compugen Earnings Date & Stock Price

  • What Is Compugen's Stock Price Today?
    A single share of CGEN can be purchased today for 1.64
  • What Is Compugen’s Stock Symbol?
    Compugen trades on the nasdaq under the ticker symbol: CGEN
  • When Is Compugen’s Next Earnings Date?
    The next quarterly earnings date for Compugen is scheduled on November 12, 2024
  • When Is CGEN's next ex-dividend date?
    Compugen's next ex-dividend date is November 5, 2024
  • How To Buy Compugen Stock?
    You can buy Compugen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Compugen Competitors

  • Who Are Compugen's Competitors?
    Below is a list of companies who compete with Compugen or are related in some way:
    • BioLine Rx Ltd (BLRX)
    • BrainsWay Ltd (BWAY)
    • Can Fite Biofarma Ltd (CANF)
    • BiomX Inc (PHGE)
    • Pluri Inc (PLUR)

Compugen Dividend Yield

  • What Is CGEN Dividend Yield?
    Compugen’s dividend yield currently is 0%
  • What Is Compugen’s Payout Ratio?
    Compugen’s payout ratio is 0%
  • When Did Compugen Last Pay A Dividend?
    The latest dividend pay date is November 5, 2024
  • What Is Compugen’s Dividend Per Share?
    Compugen pays a dividend of $0.00 per share

Compugen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 60%
Revenue: 0% 150.68%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 143.9%

Major Shareholders

  • How many CGEN shares are owned by institutional investors?
    17.5M CGEN shares are owned by institutional investors
  • How many CGEN shares are owned by insiders?
    0 CGEN shares are owned by insiders